Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NFKB1-AS1 (ENSG00000260651) is a long non-coding RNA (lncRNA) transcribed antisense to the NFKB1 gene, which encodes the NF-κB p105/p50 transcription factor subunit involved in immune and inflammatory processes. As an antisense RNA, NFKB1-AS1 may have a regulatory function on NFKB1 gene expression, but its specific biological role, clinical significance, or involvement in disease remains largely uncharacterized. This transcript is not currently regarded as a canonical therapeutic target such as a receptor, enzyme, transporter, or ion channel[3]. Essential clarification: "NFKB1 antisense RNA 1" is not the same as "NFKB1," which is a key, druggable transcription factor implicated in immunity and disease[1][5][7]. The antisense transcript has not been established in the literature or databases as a validated target for drug discovery or biological intervention[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NFKB1 antisense RNA 1 (NFKB1-AS1).